Clinical Trials in Philadelphia

Showing 4981-5000 of 15,860 trials

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

NCT04638829

Evaluate the safety and tolerability of avatrombopag given for 90 days after stopping treatment with eltrombopag or romiplostim.

Immune Thrombocytopenia

Sobi, Inc.60 participantsStarted Mar 2021

Tucson, Arizona, United States • Whittier, California, United States • Washington D.C., District of Columbia, United States +17 more locations

Active Not RecruitingPhase 2< 1 mile

A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study

NCT04215146

The purpose of this study is to find out the possible anti-cancer effect of pelareorep in combination with chemotherapy \[paclitaxel\] and avelumab in treating a type of breast cancer called Hormone Receptor positive (HR+)/Human Epidermal Growth Factor Receptor 2 negative(HER2-) breast cancer, which is either locally advanced or has metastasized (cancer that has spread in your body). The study will investigate if pelareorep in combination with paclitaxel and avelumab is more effective than paclitaxel alone, or pelareorep and paclitaxel. The safety of the combination treatments will also be evaluated.

Breast Cancer Metastatic

Oncolytics Biotech48 participantsStarted Jun 2020

Miami, Florida, United States • Urbana, Illinois, United States • Indianapolis, Indiana, United States +15 more locations

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study

Find Trials by Condition in Philadelphia

Automated Insulin Delivery in Elderly With Type 1 Diabetes (AIDE T1D)

Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

CLUSTER Trial for Outbreak Detection and Response

Saypha® VOLUME Lidocaine for Midface Augmentation

A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC

The Syn-Sleep Study

Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV Infection

Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma

Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

Nemaline Myopathy Clinical Research Network (NM-CTRN)

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002)

Evaluating Treatment of ADHD in Children with Down Syndrome

Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)

Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors